[Ovid] Efficacy and Safety of Savolitinib Plus Osimertinib in EGFR-Mutant, MET-Aberrant Advanced Non每Small Cell Lung Cancer

UAiman Post time 12 min. ago | Show all posts |Read mode
This post will be closed automatically in 2026-09-14 21:02
Reward30points

journalㄩAmerican Journal of Clinical Oncology

AuthorsㄩEshal Amir; Muhammad W. Khan; Muhammad S. Mannan; Syed M. Rayyan; Muhammad A.H. Khan; Hammad Saif; Hunain Shahbaz; Syed M. Hussain; Hamayel Khan; Muhammad Shahzaib; Mueed Iqbal; Ahmed Javed

Published dateㄩ--

DOIㄩ10.1097/coc.0000000000001367

PDF linkㄩhttps://www.ovid.com/10.1097/COC.0000000000001367

Article linkㄩhttps://doi.org/10.1097/coc.0000000000001367

Article SourceㄩOvid Technologies (Wolters Kluwer Health)


Remarkㄩ
Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

You have to log in before you can reply Login | Register

Points Rules

Junior Member
  • post

  • reply

  • points

    80


Return to the list